Skip to main content
FinSpry Logo
FinSpry
EOLS logo
EOLS
(NASDAQ)
Evolus, Inc.
$4.03-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Evolus (EOLS) Stock Price & Financial Analysis

Evolus Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.99 - $4.16
52-Week High$12.51
52-Week Low$3.86
Open$4.13
Volume837.68K
Average Volume (3M)837.68K
Market Cap259.81M
Shares Outstanding64.47M
Price to Sales (P/S)0.94
EV/EBITDA-13.88
Revenue (TTM)297.18M
Net Income (TTM)-51.64M
Free Cash Flow (TTM)-50.03M
EPS (TTM)$-0.80
Profit Margin-17.38%
Operating Margin-12.80%
50-Day MA$4.65
200-Day MA$6.63
52-Week Change-64.05%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Evolus

What is the current stock price for EOLS?

As of the latest trading session, EOLS stock trades at $4.03. The 52-week range is $3.86–$12.51, with a day range of $3.99–$4.16.

What is the P/E ratio for EOLS?

The P/E ratio (Price-to-Earnings) for EOLS is shown in the Key Statistics section. This valuation metric helps compare Evolus, Inc. to industry peers.

Does EOLS pay dividends?

Evolus does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for EOLS?

Based on 3 analysts, the consensus for EOLS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of EOLS?

Evolus's market capitalization is $259.8M, classifying it as a micro-cap company. Evolus operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.